Plant genetic engineering, which has led to the production of plant-derived monoclonal antibodies (mAbPs), offers a effective and safe option to conventional antibody expression strategies economically. understood if the shorter half-life is because of the shortage or OM of sialylation for the glycoproteins [5]. Unlike mAbs for tumor therapy, an anti-rabies mAb for PEP with… Continue reading Plant genetic engineering, which has led to the production of plant-derived